Odonate Therapeutics Inc
Change company Symbol lookup
Select an option...
ODT Odonate Therapeutics Inc
TEL TE Connectivity Ltd
BOKF BOK Financial Corp
SMBK SmartFinancial Inc
PRAA PRA Group Inc
FHN First Horizon Corp (Tennessee)
XEL Xcel Energy Inc
XEC Cimarex Energy Co
XCUR Exicure Inc
XBIT XBiotech Inc
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Odonate Therapeutics, Inc., formerly Odonate Therapeutics, LLC, is a pharmaceutical company. The Company is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. It is focused on the development of tesetaxel, a novel chemotherapy agent. It has completed Phase-II studies in patients with metastatic breast cancer (MBC). The Company's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

Premarket

Last Trade
Delayed
$3.31
-0.01 (-0.30%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.32
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
639

10-day average volume:
16,508,444
639

Latest Earnings (Q4 ending 12/2020)

Q4
-$0.83
Q4 Consensus estimate
-$0.78

Latest Earnings Estimate Range

Highest
estimate
-$0.68
Mean
estimate
-$0.78
Lowest
estimate
-$1.01

Quarterly Consensus Estimates and Ranges

ODT's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.